Match each patient presenting with severe hypertension and distinct clinical features to the most appropriate initial targeted pharmacologic intervention.
- A 65-year-old man presenting with sudden-onset, severe, tearing chest pain radiating to the interscapular region, accompanied by asymmetric pulses in the upper extremities.Intravenous beta-adrenergic blockade (e.g., esmolol)
- A 48-year-old woman with diffuse cutaneous systemic sclerosis who develops sudden oliguric acute kidney injury, microangiopathic hemolytic anemia, and a blood pressure of 230/120 mm Hg.Angiotensin-converting enzyme (ACE) inhibition (e.g., captopril)
- A 35-year-old man with a known adrenal mass who presents with paroxysmal severe hypertension, pounding headaches, diaphoresis, and tachycardia.Intravenous alpha-adrenergic blockade (e.g., phentolamine)
- A 72-year-old man with a history of heart failure with preserved ejection fraction presenting with acute severe dyspnea, hypoxia, and diffuse bilateral pulmonary crackles in the setting of a blood pressure of 210/115 mm Hg.Intravenous venodilation (e.g., nitroglycerin) alongside diuresis
Answer
Aortic dissection requires beta-blockade; Scleroderma renal crisis requires ACE inhibition; Pheochromocytoma requires alpha-blockade; Flash pulmonary edema requires venodilation and diuresis.
Each specific hypertensive emergency demands a precise pharmacological mechanism of action to counteract its pathophysiology. Using a generic approach for blood pressure lowering without addressing the specific underlying driver can lead to severe adverse outcomes.
Step-by-Step Solution
Key Concept
Targeted pharmacotherapy for specific hypertensive emergencies based on underlying pathophysiology.
Estimated Time:1m 30s